Opioid Prescribing Rates and Criminal Justice and Health Outcomes / SpringerBriefs in Criminology (PDF)

He is a member of the American Society of Criminology, and a Lifetime Member of both the Academy of Criminal Justice Sciences and the Southern Criminal Justice Association. Finally, he is currently the Vice President of the Southern Criminal Justice Association.



Nicholas Perez, Ph.D. is an Assistant Professor in the School of Criminology, Criminal Justice, and Emergency Management at California State University, Long Beach (CSULB). He has authored or co-authored peer-reviewed journal articles in Aggression and Violent Behavior, the Annual Review of Clinical Psychology, Crime & Delinquency, the Journal of Contemporary Criminal Justice, Policing: An International Journal of Police Strategies and Management, the Journal of Youth and Adolescence, Security Journal, the Journal of Criminal Justice Education, and Child Abuse & Neglect. His main research interests involve the development of delinquent behavior, policing, and opioid and prescription drug abuse. In addition to his academic appointment, he currently works as a research consultant for a Bureau of Justice Assistance (BJA) grant examining opioid prescription data in California. He is a member of both the American Society of Criminology and the Western Society of Criminology.



Chris Delcher, Ph.D., is an epidemiologist and assistant professor in the Department of Pharmacy Practice and Science and the associate director of the Institute for Pharmaceutical Outcomes and Policy at the University of Kentucky. In addition, he also a Courtesy Appointment in the Department of Health Outcomes & Biomedical Informatics and is a Faculty Affiliate of the Institute for Child Health Policy in the College of Medicine at the University of Florida. He received his Master's degree from the University of North Carolina's Gillings School of Global Public Health and his PhD in Epidemiology from the University of Florida. He has authored or co-authored more than 50 publications in leading medical and public health journals including the Annals of Internal Medicine, the American Journal of Preventive Medicine, the American Journal of Public Health, Morbidity and Mortality Weekly Report, Journal of Adolescent Health, Drug & Alcohol Dependence, and Forensic Science International and is co-author of Data Driven Approaches for Healthcare: Machine learning for Identifying High Utilizers. His research focuses on the epidemiology of prescription drug use from data obtained during medical and pharmacy encounters, understanding the intended and unintended consequences of drug policy and its effects on population health, and enhancing public health surveillance systems in high and low resource environments.



Yanning Wang, M.S., is a Data Management Analyst in the Department of Health Outcomes and Biomedical Informatics in the College of Medicine at the University of Florida. She has authored or co-authored peer-reviewed journal articles in JAMA, the Annals of Internal Medicine, the American Journal of Preventive Medicine, the American Journal of Public Health, Morbidity and Mortality Weekly Report, Drug & Alcohol Dependence, the American Journal of Epidemiology, the American Journal of Occupational Therapy, Accident Analysis & Prevention, and Forensic Science International. Her research focus is injury surveillance and prevention. She currently works on strategic planning for public health initiatives, develops and maintains a drug-related outcomes surveillance system, and leads research on drug abuse and overdose prevention funded by the US Department of Justice, Bureau of Justice Assistance. Ms. Yanning Wang was the architect for the first, publicly-available data-driven surveillance system for monitoring prescription and other drug-related outcomes in Florida. She works closely with public health and public safety agencies to develop prevention strategies to address the ongoing drug overdose epidemic. Ms. Wang has also conducted a series of studies to investigate emerging drug epidemics and evaluate the impact of national drug policies on populations vulnerable to substance abuse.